Continuous Intravenous Administration of Live Genetically Modified Salmonella Typhimurium in Patients With Metastatic Melanoma

Documenti analoghi

• Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma
  di: Toso, John F., et al.
  Pubblicazione: (2002)
• Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella Typhimurium
  di: Rosenberg, Steven A., et al.
  Pubblicazione: (2002)
• Genetic Circuits in Salmonella typhimurium
  di: Prindle, Arthur, et al.
  Pubblicazione: (2012)
• Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium
  di: Kimura, H., et al.
  Pubblicazione: (2009)
• Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma
  di: Guo, Zhu-Ling, et al.
  Pubblicazione: (2015)